Skip to main content
Mehow Innovative Ltd. logo

Mehow Innovative Ltd. — Investor Relations & Filings

Ticker · 301363 ISIN · CNE100005WP6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 498 across all filing types
Latest filing 2023-03-14 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 301363

About Mehow Innovative Ltd.

https://www.mehow.com

Mehow Innovative Ltd. specializes in the design, development, and manufacturing of high-precision medical devices and components. The company focuses on advanced manufacturing technologies, particularly Liquid Silicone Rubber (LSR) molding, multi-shot injection molding, and precision plastic components. Its core product portfolio includes respiratory care solutions, drug delivery systems, surgical instruments, and specialized medical consumables. Mehow provides comprehensive contract development and manufacturing organization (CDMO) services, encompassing product design, mold engineering, and automated assembly within controlled cleanroom environments. By integrating material science with precision engineering, the company supports global medical device manufacturers in producing complex, high-performance components for critical healthcare applications.

Recent filings

Filing Released Lang Actions
第二届监事会第二次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of Shenzhen Mehao Chuangyi Medical Technology Co., Ltd. It details the convening and decisions made at the second meeting of the second Supervisory Board, including approval of proposals related to foreign exchange hedging, use of idle funds for financial products, and opening a margin account for bank acceptance bills. The document is a formal announcement of board meeting resolutions rather than a full report or financial statement. It does not contain financial data or detailed management discussion, nor is it a regulatory certification or voting result announcement. It fits best under Board/Management Information (MANG) as it relates to internal governance decisions by the supervisory board.
2023-03-14 Chinese
东兴证券股份有限公司关于深圳市美好创亿医疗科技股份有限公司通过开立超募资金保证金账户方式开具银行承兑汇票支付超募资金投资项目款项的核查意见
Capital/Financing Update Classification · 95% confidence The document is a detailed verification opinion from Dongxing Securities regarding the use of over-raised funds by Shenzhen Meihua Chuangyi Medical Technology Co., Ltd. It discusses the procedures, approvals, and supervisory opinions related to the company's use of bank acceptance bills to pay for investment projects funded by over-raised capital. The document references regulatory approvals, board and supervisory committee meetings, independent directors' opinions, and the sponsor institution's review. It does not contain financial statements or quarterly/yearly financial results but is a formal verification and supervisory opinion report related to the company's fundraising and use of funds. This fits best under the category of Capital/Financing Update (CAP), as it concerns the management and use of raised capital and related financing procedures rather than a full financial report or audit.
2023-03-14 Chinese
关于通过开立超募资金保证金账户方式开具银行承兑汇票支付超募资金投资项目款项的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Shenzhen Mehao Chuangyi Medical Technology Co., Ltd. regarding the approval and process of opening a special escrow account to issue bank acceptance bills for payment of over-raised funds investment projects. It details the board and supervisory committee meetings approving this financial operation, the regulatory approvals for the IPO and fundraising, and the procedural controls and oversight by independent directors and the sponsor institution. The document does not contain financial statements or detailed financial results but is a formal disclosure about a financing-related operational procedure and approval. It is not a full financial report, audit report, or earnings release. It is also not a report publication announcement since it contains substantive information about the company's financing operation. This fits best under Capital/Financing Update (CAP) as it relates to the company's fundraising and capital usage updates.
2023-03-14 Chinese
关于继续开展外汇套期保值业务的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Shenzhen Mehao Chuangyi Medical Technology Co., Ltd. regarding the continuation of foreign exchange hedging business. It details the purpose, scope, risk analysis, risk control measures, accounting principles, and approvals related to the foreign exchange hedging activities. The document includes board and supervisory committee meeting resolutions, independent director opinions, and sponsor institution verification opinions. It is a regulatory announcement about the company's ongoing hedging activities and risk management, not a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial data but rather informs shareholders and the market about the company's hedging business continuation and related governance. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-03-14 Chinese
关于公司及子公司2023年度向银行申请综合授信额度的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Shenzhen Meihua Chuangyi Medical Technology Co., Ltd. regarding the company's and its subsidiaries' application for a comprehensive credit line from banks for the year 2023. It details the credit types, authorization for the chairman to handle financing within the approved limits, and the purpose of the credit line to support company operations and optimize capital structure. The document is a formal announcement of financing activity, not a financial report or detailed financial statement. It does not contain financial results, audit information, or management discussion. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is short (1068 characters), consistent with an announcement rather than a full report.
2023-03-14 Chinese
第二届董事会第二次会议决议公告
Board/Management Information Classification · 95% confidence The document is titled as a resolution announcement from the company's second board meeting, detailing decisions made by the board of directors on various financial and operational matters such as credit facilities, foreign exchange hedging, and use of idle funds. It includes voting results and references to compliance with company law and stock exchange regulations. There is no presentation of financial statements or detailed financial performance data, nor is it an earnings release or annual/interim report. The document is clearly an announcement of board decisions and management authorizations, fitting the category of Board/Management Information (MANG). The document length is about 3,000 characters, consistent with a meeting resolution announcement rather than a full report.
2023-03-14 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.